2023 annual financial data
Dogwood Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -5,446,919 USD and net income was -5,296,015 USD.
Operating cash flow was -4,870,489 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,446,919 USD
- Net income
- -5,296,015 USD
- Operating cash flow
- -4,870,489 USD